Recent Finacing
Recent Raise
Asalyxa Bio develops nano-engineered PANTHER platform therapeutics that target neutrophils and other immune cells to deliver existing and novel drugs, advancing programs such as ASX-100 for ARDS.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Asalyxa Bio.
